Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Moira Glaccum is active.

Publication


Featured researches published by Moira Glaccum.


Journal of Experimental Medicine | 2002

Cytokine Requirements for Acute and Basal Homeostatic Proliferation of Naive and Memory CD8+ T Cells

Ananda W. Goldrath; Pallavur V. Sivakumar; Moira Glaccum; Mary K. Kennedy; Michael J. Bevan; Christophe Benoist; Diane Mathis; Eric A. Butz

Both naive and memory T cells undergo antigen-independent proliferation after transfer into a T cell–depleted environment (acute homeostatic proliferation), whereas only memory T cells slowly divide in a full T cell compartment (basal proliferation). We show, first, that naive and memory CD8+ T cells have different cytokine requirements for acute homeostatic proliferation. Interleukin (IL)-7 receptor(R)α–mediated signals were obligatory for proliferation of naive T cells in lymphopenic hosts, whereas IL-15 did not influence their division. Memory T cells, on the other hand, could use either IL-7Rα– or IL-15–mediated signals for acute homeostatic proliferation: their proliferation was delayed when either IL-7Rα was blocked or IL-15 removed, but only when both signals were absent was proliferation ablated. Second, the cytokine requirements for basal and acute homeostatic proliferation of CD8+ memory T cells differ, as basal division of memory T cells was blocked completely in IL-15–deficient hosts. These data suggest a possible mechanism for the dearth of memory CD8+ T cells in IL-15– and IL-15Rα–deficient mice is their impaired basal proliferation. Our results show that naive and memory T lymphocytes differ in their cytokine dependence for acute homeostatic proliferation and that memory T lymphocytes have distinct requirements for proliferation in full versus empty compartments.


Journal of Immunology | 2002

Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice

Erika Cretney; Kazuyoshi Takeda; Hideo Yagita; Moira Glaccum; Jacques J. Peschon; Mark J. Smyth

We have previously implicated TNF-related apoptosis-inducing ligand (TRAIL) in innate immune surveillance against tumor development. In this study, we describe the use of TRAIL gene-targeted mice to demonstrate the key role of TRAIL in suppressing tumor initiation and metastasis. Liver and spleen mononuclear cells from TRAIL gene-targeted mice were devoid of TRAIL expression and TRAIL-mediated cytotoxicity. TRAIL gene-targeted mice were more susceptible to experimental and spontaneous tumor metastasis, and the immunotherapeutic value of α-galactosylceramide was diminished in TRAIL gene-targeted mice. TRAIL gene-targeted mice were also more sensitive to the chemical carcinogen methylcholanthrene. These results substantiated TRAIL as an important natural effector molecule used in the host defense against transformed cells.


European Journal of Immunology | 2002

Characterization of the in vivo function of TNF-α-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice

Lisa M. Sedger; Moira Glaccum; JoAnn C. L. Schuh; Suzanne T. Kanaly; Eilidh Williamson; Nobuhiko Kayagaki; Theordore Yun; Pam Smolak; Tiep Le; Ray Goodwin; Brian Gliniak

To define the normal physiological role for the TRAIL/Apo2L in vivo, we generated TRAIL/Apo2L gene‐targeted mice. These mice develop normally and show no defects in lymphoid or myeloid cell homeostasis or function. Although TRAIL/Apo2L kills transformed cells in vitro, TRAIL/Apo2L–/– mice do not spontaneously develop overt tumors at an early age. However, in the A20 B cell lymphoma‐transferred tumor model, TRAIL/Apo2L–/– mice are clearly more susceptible to death from overwhelming tumor burden, due to increased lymphoma load in the liver. A20 tumors are susceptible to TRAIL/Apo2L killing in vitro, indicating that TRAIL/Apo2L may act directly to control A20 cells in vivo. Despite the fact that TRAIL binds osteoprotegerin and osteoprotegerin‐transgenic mice are osteopetrotic, TRAIL/Apo2L–/– mice show no evidence of altered gross bone density, and no alterations in frequency or in vitro differentiationof bone marrow precursor osteoclasts. Moreover, leucine zipper TRAIL has no toxicity when repeatedly administered to osteoprotegerin–/– mice. Thus, TRAIL/Apo2L is important in controlling tumors in vivo, but is not an essential regulator of osteoprotegerin‐mediated biology, under normal physiological conditions.


Current Biology | 2002

RIP4 Is an Ankyrin Repeat-Containing Kinase Essential for Keratinocyte Differentiation

Pamela M. Holland; Cynthia R. Willis; Suzanne T. Kanaly; Moira Glaccum; Annjanette S. Warren; Keith Charrier; J.Greg Murison; Jonathan M.J. Derry; G. Duke Virca; Timothy A. Bird; Jacques J. Peschon

The epidermis is a stratified, continually renewing epithelium dependent on a balance among cell proliferation, differentiation, and death for homeostasis. In normal epidermis, a mitotically active basal layer gives rise to terminally differentiating keratinocytes that migrate outward and are ultimately sloughed from the skin surface as enucleated squames. Although many proteins are known to function in maintaining epidermal homeostasis, the molecular coordination of these events is poorly understood. RIP4 is a novel RIP (receptor-interacting protein) family kinase with ankyrin repeats cloned from a keratinocyte cDNA library. RIP4 deficiency in mice results in perinatal lethality associated with abnormal epidermal differentiation. The phenotype of RIP4(-/-) mice in part resembles that of mice lacking IKKalpha, a component of a complex that regulates NF-kappaB. Despite the similar keratinocyte defects in RIP4- and IKKalpha-deficient mice, these kinases function in distinct pathways. RIP4 functions cell autonomously within the keratinocyte lineage. Unlike IKKalpha, RIP4-deficient skin fails to fully differentiate when grafted onto a normal host. Instead, abnormal hair follicle development and epidermal dysplasia, indicative of progression into a more pathologic state, are observed. Thus, RIP4 is a critical component of a novel pathway that controls keratinocyte differentiation.


Journal of Immunology | 2002

Bone Marrow B Cell Apoptosis During In Vivo Influenza Virus Infection Requires TNF-α and Lymphotoxin-α

Lisa M. Sedger; Sam Hou; Sarah R. Osvath; Moira Glaccum; Jacques J. Peschon; Nico van Rooijen; Lisa Hyland

Suppression of bone marrow myeloid and erythroid progenitor cells occurs after infection with a variety of different viruses. In this study, we characterize the alterations in bone marrow (BM) lymphocytes after influenza virus infection in mice. We found a severe loss of BM B cells, particularly CD43low/−B220+ pre-B and immature B cells, in influenza virus-infected mice. Depletion of BM B lineage cells resulted primarily from cell cycle arrest and most likely apoptosis within the BM environment, rather than from increased trafficking of BM emigrants to peripheral lymphoid tissues. Use of gene-knockout mice indicates that depletion of BM B cells is dependent on TNF-α, lymphotoxin-α, and both TNF receptors, TNFR1-p55 and TNFR2-p75. Thus, TNF-α and lymphotoxin-α are required for loss of BM B lineage cells during respiratory infection with influenza virus.


Archive | 1998

Functional Phenotype of Mice Deficient in the IL-1R Type I Gene

Philip J. Morrissey; Moira Glaccum; Charles R. Maliszewski; Jacques J. Peschon

Interleukin 1 (IL-1) is a cytokine that is involved in the mechanism of host resistance and immune function (for review, see ref. 1). Evidence indicates that IL-1 functions as a proinflammatory cytokine with significant and well-documented effects on innate resistance and the inflammatory response (2). The biological effects of IL-1 also influence the development of the specific immune response. IL-1 has been long studied as a costimulator of both B-cells and T-cells and the adjuvant effect of IL-1 is well documented (3–5). Thus, it is believed that IL-1 plays a central role in both innate resistance mechanisms and specific immune responses.


Journal of Experimental Medicine | 2000

Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice

Mary K. Kennedy; Moira Glaccum; Sandra N. Brown; Eric A. Butz; Joanne L Viney; Monica E. Embers; Naoto Matsuki; Keith Charrier; Lisa M. Sedger; Cynthia R. Willis; Kenneth Brasel; Philip J. Morrissey; Kim L. Stocking; JoAnn C. L. Schuh; Sebastian Joyce; Jacques J. Peschon


Genes & Development | 1999

RANK is essential for osteoclast and lymph node development

William C. Dougall; Moira Glaccum; Keith Charrier; Kathy Rohrbach; Kenneth Brasel; Thibaut De Smedt; Elizabeth Daro; Jeffery Smith; Mark E. Tometsko; Charles R. Maliszewski; Allison P. Armstrong; Victor Shen; Steven D. Bain; David Cosman; Dirk M. Anderson; Philip J. Morrissey; Jacques J. Peschon; JoAnn C. L. Schuh


Journal of Immunology | 1998

TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation

Jacques J. Peschon; Dauphine Torrance; Kim L. Stocking; Moira Glaccum; Carol Otten; Cynthia R. Willis; Keith Charrier; Philip J. Morrissey; Carol B. Ware; Kendall M. Mohler


Journal of Immunology | 1997

PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF MICE THAT LACK THE TYPE I RECEPTOR FOR IL-1

Moira Glaccum; Kim L. Stocking; Keith Charrier; J L Smith; Cynthia R. Willis; Charles R. Maliszewski; D J Livingston; Jacques J. Peschon; Philip J. Morrissey

Collaboration


Dive into the Moira Glaccum's collaboration.

Researchain Logo
Decentralizing Knowledge